Similarly, in colon cancer, the silencing of IDO1 inhibits the expression of β-catenin in the nucleus, as well as the expression of Axin2 and Cyclin D1, further exerting an inhibitory effect on tumor proliferation [84]. The gene discussed is CCND1; the disease is neoplasm.